Form D · Other Health Care
Vixiar Medical, Inc.
Annapolis, MD · CIK 0001589946
Offering snapshot reported Mar 16, 2018 · SEC filing
- Reported sold
- $1.58M Offering amount: $1.82M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $20K Reported outside-investor minimum
- First sale
- Sep 6, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 16, 2018 | Initial | $1,580,000 | No comparison | 5 | SEC filing |
| Oct 24, 2013 | Initial | $143,750 | No comparison | 20 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-307946
Shares in exchange for the conversion and cancellation of outstanding convertible promissory notes
Source: Form D, filed Mar 16, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Calvin Goforth | Director |
| R. Calvin Goforth | Director |
| Mark Kidd | Executive |
| Robert Storey | Director, Executive |
| Bob Storey | Director |
| Kevin Thibodeau | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
91 Main Street
Annapolis, MD, 21401
Annapolis, MD, 21401